Smartleaf Asset Management LLC Sells 382 Shares of Humana Inc. (NYSE:HUM)

Smartleaf Asset Management LLC reduced its position in Humana Inc. (NYSE:HUM) by 33.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 751 shares of the insurance provider’s stock after selling 382 shares during the period. Smartleaf Asset Management LLC’s holdings in Humana were worth $191,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Creative Financial Designs Inc. ADV boosted its stake in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 61 shares in the last quarter. FPC Investment Advisory Inc. acquired a new stake in shares of Humana in the 4th quarter worth $27,000. Centricity Wealth Management LLC purchased a new position in Humana during the 4th quarter worth $30,000. Ashton Thomas Securities LLC purchased a new position in Humana during the 3rd quarter worth $31,000. Finally, Atwood & Palmer Inc. increased its position in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after buying an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.32% of the stock is currently owned by company insiders.

Humana Trading Down 0.3 %

HUM stock opened at $262.10 on Thursday. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $31.62 billion, a P/E ratio of 26.34, a PEG ratio of 2.05 and a beta of 0.57. The company’s 50-day simple moving average is $271.53 and its 200-day simple moving average is $284.92.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is presently 35.58%.

Analyst Ratings Changes

Several research firms have recently issued reports on HUM. Barclays upped their price objective on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Truist Financial lifted their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Finally, Morgan Stanley reduced their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Twenty investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus target price of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.